Dr. Sabet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Gold Coast
Australia
Lexington, KY 40505
Education & Training
Duke University HospitalFellowship, Clinical Neurophysiology, 2000 - 2001- Duke University HospitalResidency, Neurology, 1997 - 2000
- Duke University HospitalInternship, Internal Medicine, 1996 - 1997
University of New Mexico School of MedicineClass of 1996
Certifications & Licensure
KY State Medical License 2001 - 2012
Clinical Trials
- Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease Start of enrollment: 2019 Jan 09
Roles: Contact
- EMERALD TRIAL Open Label Extension Study Start of enrollment: 2021 May 17
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsStudy protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression o...Berzenn Urbi, Simon Broadley, Richard Bedlack, Ethan Russo, Arman Sabet
BMJ Open. 2019-11-01 - 22 citationsTime to diagnosis in the National Registry of Veterans with Amyotrophic Lateral SclerosisNatan Khishchenko, Kelli D. Allen, Cynthia J. Coffman, Edward J. Kasarskis, Jennifer H. Lindquist
Amyotrophic Lateral Sclerosis. 2009-01-01 - 41 citationsThe National Registry of Veterans with amyotrophic lateral sclerosis.Kelli D. Allen, E. J. Kasarskis, Richard Bedlack, Marvin P. Rozear, Joel C. Morgenlander
Neuroepidemiology. 2008-04-18
Press Mentions
CannTrust Partnering with Australian Hospital for Trial Testing Cannabidiol Capsules for ALSJuly 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
